Print Article
BookMark Article
10 newest articles RSS
Viagra Patent - What You Need To Know
Author : Jewell V Woods
Submitted : 2011-11-15 Word Count : 870 Popularity: Not Rated
Tags: Viagra Patent, Viagra Patent rights
Did you know that Pfizer would not have the rights for Viagra patent come 27th March, 2012? This information is according to the United States Patent and Trademark Office. After 27th March, 2012, any pharmaceutical company will be in a position to manufacture and sell affordable generic variation of the popular erectile dysfunction (ED) medication. A majority of attorneys and doctors think that the end of Pfizer's domination on the medicine will be pleasant news for most patients. This is because; it will compel competition between the genuine Viagra and generic variations, thus bringing down the cost for the medicine by a considerable margin.
Nevertheless, increased alternatives as well as affordable costs for patients will give rise to mayhem in the market as Pfizer has relied heavily on the status of the actual brand and pharmaceutical stores will flood the market with generic medications that will mainly come from China. The following are some of the things you need to know about Viagra patent as the date for the inception of generics into the market nears.
Viagra, Levitra as well as Cialis are the only erectile dysfunction medications presently permitted by the Food and Drug Administration (FDA) in the United States. Of the three medications, Viagra is the oldest. As such, it will be the first drug to lose its control status. After the Viagra patent has expired, the sluicegates will open and patients will probably be barraged with promotions for affordable ED medications. However, the law will not permit them to utilize the name Viagra when branding their products. Since its inception into the market, Pfizer has raised the cost of Viagra by at least 5% on a yearly basis and it's expected that with the expiry of the Viagra patent, the cost will reduce drastically.
There Are the Likelihoods of Legal Stress from Generics for Pfizer
As the time line for Viagra patent expiration approaches, customers can see generic medication manufacturers creating legal moves to bring the deadline to a near date than the one set. There is the likelihood that generic companies will compel FDA to allow them to launch their generic variations before the expiration date. There is also the possibility that they will sue Pfizer claiming that the company's patent is invalid.
Interestingly enough, Pfizer has not opposed the end of their monopoly. The company has not given any clue as to how they will manage a post Viagra patent.
Author's Resource Box
Jewell V Woodsis the content director for AccessRx.com, an online medication facilitator specializing in facilitating medications such as Viagra Patent to patients. At AccessRx.com, consumers can buy buy Viagra in the convenience of their home or office.